The International Journal of Cancer Management is a distinguished publication dedicated to advancing knowledge and research in the fields of cancer management, oncology, pharmacology, and radiology. Published by BRIEFLAND in the Netherlands, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in cancer care and treatment strategies. With an ISSN of 2538-4422 and an E-ISSN of 2538-497X, the journal features a range of peer-reviewed articles that cover diverse aspects of cancer management, reflecting its commitment to high-quality, impactful research. The journal ranks in the Q4 category for Cancer Research and Oncology and Q3 for both Pharmacology and Surgery in 2023, signifying its growing influence in the scientific community. Through its open access format, the International Journal of Cancer Management ensures that critical research findings are accessible to all, promoting collaboration and innovation in the battle against cancer. Researchers looking to share their findings or learn more about current trends will find this journal an invaluable addition to their professional toolkit.

Current Oncology Reports is a prestigious academic journal dedicated to the field of oncology, published by Springer and based in the United States. With an impressive impact factor and ranking as a Q1 journal in the 2023 category of Oncology, it positions itself among the top-tier publications within the discipline. Established in 1999, the journal has been a vital resource for researchers, professionals, and students alike, providing comprehensive insights and the latest advancements in cancer research and treatment. Through its rigorous peer-review process, Current Oncology Reports disseminates high-quality original articles, reviews, and clinical studies that foster collaboration and innovation in the oncology community. Although it currently operates under a subscription model, the journal remains committed to accessibility, ensuring that critical findings reach a broad audience. As such, it serves as an essential platform for those dedicated to the fight against cancer, making significant contributions to the evolving landscape of oncology.

SUPPORTIVE CARE IN CANCER is a premier academic journal published by Springer, dedicated to advancing the understanding and management of supportive care for cancer patients. With a notable impact factor, the journal is recognized for its contribution to the fields of Oncology, Rehabilitation, and Nursing, achieving impressive rankings in Scopus, including Q1 for Oncology Nursing and Rehabilitation, and Q2 for general Oncology. Founded in 1993 and looking towards a promising future until 2024, it serves as a vital resource for researchers, professionals, and students engaged in these critical areas of healthcare. Although not an Open Access journal, its rigorous peer-reviewed articles provide valuable insights into innovative practices and evidence-based strategies that enhance patient quality of life during and after treatment. By bridging the gap between research and clinical practice, SUPPORTIVE CARE IN CANCER significantly influences patient outcomes and fosters interdisciplinary collaboration in patient support.

Onkologija is a distinguished open-access journal dedicated to the field of oncology, published by the Institute of Oncology Ljubljana. With its ISSN 1408-1741 and E-ISSN 1581-3215, this journal has become a crucial platform for researchers and healthcare professionals since its transition to open-access in 2008, allowing widespread dissemination of critical findings and innovations in cancer research and treatment. Located in Ljubljana, Slovenia, the journal aims to bridge the gap between clinical practice and research by publishing high-quality original articles, reviews, and case studies that address pivotal issues in oncology. Although specific metrics such as HIndex and Scopus ranks are currently unavailable, Onkologija’s commitment to advancing oncology knowledge is evident in its engaging publications that attract a diverse readership, making it an essential resource for anyone invested in the battle against cancer.

Frontiers in Oncology is a premier open access journal dedicated to advancing the field of oncology through innovative research and knowledge dissemination. Published by FRONTIERS MEDIA SA since 2011, this journal is based in Switzerland and holds an impressive Q2 ranking in both Cancer Research and Oncology as of 2023, highlighting its significance in the academic community. With its commitment to open access, Frontiers in Oncology ensures that vital research is readily available to researchers, healthcare professionals, and students around the globe, enhancing collaboration and fostering breakthroughs in cancer research. The journal's robust Scopus rankings further illustrate its academic influence, with notable positions in the fields of Oncology and Cancer Research. By covering a wide range of topics within oncology, this journal serves as a vital resource, supporting the rapid evolution of cancer treatment, diagnostics, and patient care strategies.

European Journal of Oncology Nursing, published by ELSEVIER SCI LTD, is a premier, peer-reviewed journal dedicated to advancing the field of oncology nursing. With an impactful presence in the academic community, it holds a commendable Q2 ranking in the field of Medicine (miscellaneous) and a Q1 ranking in Oncology (nursing) for 2023, reflecting its significant contribution to nursing research and practice. The journal boasts a strong influence with a Scopus ranking of 7 out of 20 in its category, placing it in the 67th percentile. Since its inception in 1998, it has continued to provide a vital platform for disseminating quality research pertaining to the nursing care of cancer patients. Although it currently does not offer open access, the journal remains an essential resource for researchers, professionals, and students seeking to enhance their understanding of oncology nursing and improve patient care outcomes. Located in the United States, this journal is committed to fostering knowledge and promoting evidence-based practices in oncology nursing for years to come.

The American Journal of Hospice & Palliative Medicine, published by SAGE Publications Inc, is a leading peer-reviewed journal dedicated to advancing the field of hospice and palliative medicine. With its ISSN 1049-9091 and E-ISSN 1938-2715, the journal has been a vital resource since its inception in 1984, aiming to provide comprehensive insights into clinical practices, innovations, and research findings that enrich the quality of life for patients with serious illnesses. It holds a prestigious position as a Q2 journal in the field of medicine (miscellaneous), ranked #139 out of 636 in General Medicine with an impressive 78th percentile standing according to Scopus. The journal does not currently operate under an Open Access model, ensuring rigorous review and quality control of its content. Researchers, clinicians, and students are encouraged to engage with the latest developments and evidence-based practices in palliative care as the journal continues to shape discussions and policies in this critical area of healthcare.

AGE AND AGEING is a premier peer-reviewed journal published by Oxford University Press, dedicated to advancing the field of gerontology and related medical disciplines. With its ISSN of 0002-0729 and E-ISSN 1468-2834, the journal has established itself as a critical platform for disseminating innovative research since its inception in 1972. It boasts impressive rankings within the Q1 category in Aging, Geriatrics and Gerontology, and Miscellaneous Medicine, reflecting its influential position in the scientific community. Researchers and practitioners alike value the journal's focus on the clinical, biological, and social aspects of aging, providing a multidisciplinary approach essential for addressing the challenges of an aging population. The journal maintains a significant impact factor, demonstrating its contribution to scholarly communication and knowledge dissemination. Although it does not operate under an open access model, AGE AND AGEING remains an essential resource for those committed to understanding the complexities of aging and enhancing the quality of life for older adults.

PROGRESS IN PALLIATIVE CARE, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing the field of palliative care through high-quality research and innovative practices. With an ISSN of 0969-9260 and an E-ISSN of 1743-291X, this journal serves as a critical resource for healthcare professionals, researchers, and students seeking to enhance their understanding of pain management, symptom relief, and holistic care approaches for patients with life-limiting illnesses. Operating without an open access model, the journal is well-regarded in the academic community, holding a Q3 ranking in Medicine (miscellaneous) and a Q2 ranking in Nursing (miscellaneous) as of 2023. Its Scopus ranking places it at rank #51 out of 139 in General Nursing, reflecting its relevance and quality within the field. Covering the period from 2001 to 2024, it aims to foster interdisciplinary dialogue and share vital research findings to improve palliative care practices, ultimately enhancing patient care and outcomes.

Lung Cancer Management, published by FUTURE MEDICINE LTD, is a premier academic journal dedicated to the evolving field of oncology and respiratory medicine. With an ISSN of 1758-1966 and an E-ISSN of 1758-1974, this journal offers a platform for the dissemination of cutting-edge research, clinical studies, and expert reviews, all focusing on the latest advances in lung cancer treatment and management. Despite being a relatively new entry since its inception in 2014 and achieving its converged years from 2020 to 2024, it has already established itself in the Q3 quartile for both oncology and pulmonary and respiratory medicine as of 2023, according to category quartiles rankings. With a Scopus ranking of #98 in the category of Pulmonary and Respiratory Medicine and #266 in Oncology, the journal reflects a commitment to quality and relevance in its content. Although it does not offer open access, it remains a crucial resource for researchers, clinicians, and students seeking to stay informed about the latest developments and practical approaches in lung cancer management. The journal is accessible from its base in the United Kingdom, at UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ensuring that it caters to a global audience eager to explore and contribute to this vital field of medicine.